NSQAP: Newborn Screening Quality Assurance Program
Newborn screening identifies conditions that can affect a child’s long-term health or survival. CDC’s Newborn Screening and Molecular Biology Branch manages the Newborn Screening Quality Assurance Program (NSQAP) to enhance and maintain the quality and accuracy of newborn screening results. The program provides training, consultation, proficiency testing, guidelines, and materials to state public health laboratories and other laboratories responsible for newborn screening in the U.S. and many other countries.
A2LA Accredited Proficiency Testing Provider
CDC’s Newborn Screening and Molecular Biology Branch (NSMBB) has been granted ISO/IEC 17043 accreditation by the American Association for Laboratory Accreditation (A2LA). Accreditation was achieved after a thorough review of its quality management system and competence to develop and administer specific proficiency testing protocols. NSMBB’s Newborn Screening Quality Assurance Program (NSQAP) web-based proficiency testing programs are included in the A2LA Scope of Accreditation. Testing for Glucose-6-phosphate Dehydrogenase and NSMBB non-web-based proficiency testing programs are not included in the scope of accreditation. Please consult A2LA Certificate #4190.01 for a list of accredited NSMBB proficiency testing programs.
- Page last reviewed: July 6, 2017
- Page last updated: August 31, 2017
- Content source: